Lonza Creates 115 New Jobs
Published: Friday, Oct 13th 2023, 07:30
Mise à jour le : Vendredi, 13 octobre 2023, 14:12
Retour au fil d'actualité
Lonza, a Swiss biotechnology company, has announced plans to build a new filling plant for antibody-based drugs in Stein, Aargau. The new facility is expected to create 115 new jobs and begin operations in 2027. The plant will be used to fill and package antibody-based drugs for the global market. The new facility is part of Lonza's ongoing commitment to invest in the region and create new jobs. The company is also investing in research and development to ensure the highest quality products. The new plant is expected to bring economic benefits to the region, including increased employment opportunities and increased tax revenue. The new facility will also help to reduce the environmental impact of drug production, as it will use renewable energy sources and advanced technologies to reduce waste and emissions.
©Keystone/SDA
French 
English 
German 
Spanish 
Arabic